Insider Ledger
Moderna, Inc. (MRNA) insider buying and SEC filings
Moderna, Inc. · CIK 1682852
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Moderna Therapeutics, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$80.5M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 14–15, 2026 | Planned (10b5-1) | Stephen Hoge (President / COO) sold 78,369 shares between Oct 14 and Oct 15 at about $217.10 ($17.0M), marked as a 10b5-1 plan trade. Holdings down 5% to 1,636,565 shares. | SEC filing Filed Oct 16, 2026, 4:09 PM ET |
| Sep 14–15, 2026 | Planned (10b5-1) | Stephen Hoge (President / COO) sold 80,575 shares between Sep 14 and Sep 15 at about $145.10 ($11.7M), marked as a 10b5-1 plan trade. Holdings down 5% to 1,562,029 shares. | SEC filing Filed Sep 16, 2026 |
| Sep 10, 2026 | Planned (10b5-1) | James M Mock (CFO) sold 34,836 shares at $134.49 ($4.7M), marked as a 10b5-1 plan trade. Holdings down 37% to 59,375 shares. | SEC filing Filed Sep 14, 2026 |
| Sep 1, 2026 | Planned (10b5-1) | Shannon Thyme Klinger (Chief Legal Officer) sold 3,471 shares at $139.95 ($486K), marked as a 10b5-1 plan trade. Holdings down 4% to 74,129 shares. | SEC filing Filed Sep 3, 2026 |
| Aug 5, 2026 | Planned (10b5-1) | Stephane Bancel (CEO and Director) sold 499,246 shares at about $57.52 ($28.7M), marked as a 10b5-1 plan trade. Holdings down 7% to 6,187,791 shares. | SEC filing Filed Aug 7, 2026 |
| Jul 15, 2026 | Planned (10b5-1) | Stephen Hoge (President / COO) sold 53,336 shares at $67.60 ($3.6M), marked as a 10b5-1 plan trade. Holdings down 3% to 1,483,848 shares. | SEC filing Filed Jul 16, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Stephen Hoge (President / COO) sold 53,336 shares at $51.37 ($2.7M), marked as a 10b5-1 plan trade. Holdings down 3% to 1,483,848 shares. | SEC filing Filed Jun 17, 2026 |
| Jun 4, 2026 | Planned (10b5-1) | Shannon Thyme Klinger (Chief Legal Officer) sold 3,471 shares at $50.00 ($174K), marked as a 10b5-1 plan trade. Holdings down 5% to 67,468 shares. | SEC filing Filed Jun 8, 2026 |
| May 15, 2026 | Planned (10b5-1) | Stephen Hoge (President / COO) sold 53,336 shares at $48.40 ($2.6M), marked as a 10b5-1 plan trade. Holdings down 3% to 1,477,997 shares. | SEC filing Filed May 18, 2026 |
| May 1, 2026 | Planned (10b5-1) | Abbas Hussain (Director) sold 5,682 shares at $46.63 ($265K), marked as a 10b5-1 plan trade. Holdings down 32% to 12,066 shares. | SEC filing Filed May 4, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Shannon Thyme Klinger (Chief Legal Officer) sold 13,885 shares at $52.29 ($726K), marked as a 10b5-1 plan trade. Holdings down 19% to 59,689 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Stephen Hoge (President / COO) sold 160,009 shares at $48.84 ($7.8M), marked as a 10b5-1 plan trade. Holdings down 10% to 1,457,427 shares. | SEC filing Filed Feb 25, 2026 |
| Dec 9, 2025 | Planned (10b5-1) | Abbas Hussain (Director) sold 504 shares at $27.60 ($14K), marked as a 10b5-1 plan trade. Holdings down 25% to 1,515 shares. | SEC filing Filed Dec 11, 2025 |
65 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MRNA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.